Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin pharmacokinetics in critically ill ICU patients with invasive candidiasis
NL-OMON37779Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of micafungin in invasive candidiasis and invasive mycoses, sponsored by University Medical Center Groningen. Primary endpoint: Correlation of micafungin pharmacokinetics and plasma concentration with disease severity. Started Dec 2012; status: active, not recruiting.
02
Drugs
micafungin
03
Conditions
invasive candidiasisinvasive mycoses
Beyond the preview
Go deeper on NL-OMON37779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37779.